Compare PETS & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PETS | SQNS |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Semiconductors |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7M | 46.9M |
| IPO Year | 2003 | 2011 |
| Metric | PETS | SQNS |
|---|---|---|
| Price | $2.01 | $3.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $20.33 |
| AVG Volume (30 Days) | ★ 78.4K | 66.3K |
| Earning Date | 06-09-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $273,800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.98 | $49.79 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $0.73 |
| 52 Week High | $4.10 | $10.93 |
| Indicator | PETS | SQNS |
|---|---|---|
| Relative Strength Index (RSI) | 51.75 | 54.41 |
| Support Level | $1.87 | $2.86 |
| Resistance Level | $2.15 | $3.27 |
| Average True Range (ATR) | 0.04 | 0.19 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 43.75 | 64.94 |
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.